Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2735.99 (Glytoucan)

Id:598d8c50-9d0c-57ee-a2d6-c767e5aacc6f

Glytoucan:G13720TX

Results found

Linked to

	Label	Description
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G16743PO-GLYCOSEQ00039379 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G41596PV-GLYCOSEQ00069006 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has canonical residue n-glycan a-d-galp 52 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G52801WH-GLYCOSEQ00152835 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G01779GQ-GLYCOSEQ00087170 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G45110PO-GLYCOSEQ00057651 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G81294ZY-GLYCOSEQ00109526 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G16743PO-GLYCOSEQ00039379 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000018 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G41596PV-GLYCOSEQ00069006 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has canonical residue n-glycan a-d-galp 52

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G52801WH-GLYCOSEQ00152835 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G01779GQ-GLYCOSEQ00087170 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G45110PO-GLYCOSEQ00057651 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 has glycosequence GLYGEN.GLYCOSEQUENCE:G81294ZY-GLYCOSEQ00109526 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2735.99 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000014 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.